498 related articles for article (PubMed ID: 33428584)
1. Landscape of natural killer cell activity in head and neck squamous cell carcinoma.
Charap AJ; Enokida T; Brody R; Sfakianos J; Miles B; Bhardwaj N; Horowitz A
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428584
[TBL] [Abstract][Full Text] [Related]
2. CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.
Wang H; Nan S; Wang Y; Xu C
J Cell Mol Med; 2021 May; 25(10):4596-4607. PubMed ID: 33733587
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Impact of Targeting CEACAM1 in Head and Neck Squamous Cell Carcinoma.
Tam K; Schoppy DW; Shin JH; Tay JK; Moreno-Nieves U; Mundy DC; Sunwoo JB
Otolaryngol Head Neck Surg; 2018 Jul; 159(1):76-84. PubMed ID: 29436278
[TBL] [Abstract][Full Text] [Related]
4. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.
Crist M; Yaniv B; Palackdharry S; Lehn MA; Medvedovic M; Stone T; Gulati S; Karivedu V; Borchers M; Fuhrman B; Crago A; Curry J; Martinez-Outschoorn U; Takiar V; Wise-Draper TM
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36328378
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of HLA-B-associated transcript 3 impairs the tumoricidal effect of natural killer cells through promoting the T cell immunoglobulin and mucin domain-containing-3 signaling in a mouse head and neck squamous cell carcinoma model.
Yang J; Xiang J; Zhu M; Zhao Y; Zhou L; Hu B; Wang C
Immunobiology; 2022 Jan; 227(1):152127. PubMed ID: 34968777
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
Greene S; Robbins Y; Mydlarz WK; Huynh AP; Schmitt NC; Friedman J; Horn LA; Palena C; Schlom J; Maeda DY; Zebala JA; Clavijo PE; Allen C
Clin Cancer Res; 2020 Mar; 26(6):1420-1431. PubMed ID: 31848188
[TBL] [Abstract][Full Text] [Related]
7. Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment.
Moreno-Nieves UY; Tay JK; Saumyaa S; Horowitz NB; Shin JH; Mohammad IA; Luca B; Mundy DC; Gulati GS; Bedi N; Chang S; Chen C; Kaplan MJ; Rosenthal EL; Holsinger FC; Divi V; Baik FM; Sirjani DB; Gentles AJ; Newman AM; Freud AG; Sunwoo JB
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244432
[TBL] [Abstract][Full Text] [Related]
8. Impaired intratumoral natural killer cell function in head and neck carcinoma.
Mele D; Pessino G; Trisolini G; Luchena A; Benazzo M; Morbini P; Mantovani S; Oliviero B; Mondelli MU; Varchetta S
Front Immunol; 2022; 13():997806. PubMed ID: 36341402
[TBL] [Abstract][Full Text] [Related]
9. The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites.
Wondergem NE; Nauta IH; Muijlwijk T; Leemans CR; van de Ven R
Curr Oncol Rep; 2020 Jun; 22(8):81. PubMed ID: 32602047
[TBL] [Abstract][Full Text] [Related]
10. Exploring NK-Cell molecules that impact the immune response and microenvironment in head and neck squamous cell carcinoma.
Shao P; Hu WW; Shi XL; Shu MY; Li DY; Zhou T; Zhao QT
J Cell Mol Med; 2024 Jan; 28(2):e18045. PubMed ID: 38011007
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of natural killer cell therapy combined with chemoradiotherapy in murine models of head and neck squamous cell carcinoma.
Jung EK; Chu TH; Kim SA; Vo MC; Nguyen VT; Lee KH; Jung SH; Yoon M; Cho D; Lee JJ; Yoon TM
Cytotherapy; 2024 Mar; 26(3):242-251. PubMed ID: 38142382
[TBL] [Abstract][Full Text] [Related]
12. Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer.
Yang F; Yuan C; Chen F; Qin ZS; Schmitt NC; Lesinski GB; Saba NF; Teng Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):76. PubMed ID: 38468260
[TBL] [Abstract][Full Text] [Related]
13. Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.
Bhattacharya S; Muhammad N; Steele R; Kornbluth J; Ray RB
Cancer Prev Res (Phila); 2017 Jun; 10(6):337-344. PubMed ID: 28465362
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer.
Jung EK; Chu TH; Vo MC; Nguyen HPQ; Lee DH; Lee JK; Lim SC; Jung SH; Yoon TM; Yoon MS; Cho D; Lee JJ; Cho HH
Cytotherapy; 2022 Sep; 24(9):905-915. PubMed ID: 35778350
[TBL] [Abstract][Full Text] [Related]
15. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
[TBL] [Abstract][Full Text] [Related]
16. CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma.
Ciulean IS; Fischer J; Quaiser A; Bach C; Abken H; Tretbar US; Fricke S; Koehl U; Schmiedel D; Grunwald T
Front Immunol; 2023; 14():1290488. PubMed ID: 38022580
[TBL] [Abstract][Full Text] [Related]
17. Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer.
Jacobs MT; Wong P; Zhou AY; Becker-Hapak M; Marin ND; Marsala L; Foster M; Foltz JA; Cubitt CC; Tran J; Russler-Germain DA; Neal C; Kersting-Schadek S; Chang L; Schappe T; Pence P; McClain E; Zevallos JP; Rich JT; Paniello RC; Jackson RS; Pipkorn P; Adkins DR; DeSelm CJ; Berrien-Elliott MM; Puram SV; Fehniger TA
Clin Cancer Res; 2023 Oct; 29(20):4196-4208. PubMed ID: 37556118
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of circulating natural killer cells in head and neck squamous cell carcinoma.
Böttcher A; Ostwald J; Koczan D; Knecht R; Kramp B; Dommerich S
Cancer Genomics Proteomics; 2013; 10(5):197-207. PubMed ID: 24136972
[TBL] [Abstract][Full Text] [Related]
19. CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model.
Yun J; Saddawi-Konefka R; Goldenson B; Al-Msari R; Bernareggi D; Thangaraj JL; Tang S; Patel SH; Luna SM; Gutkind JS; Kaufman D
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38702144
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.
Weil S; Memmer S; Lechner A; Huppert V; Giannattasio A; Becker T; Müller-Runte A; Lampe K; Beutner D; Quaas A; Schubert R; Herrmann E; Steinle A; Koehl U; Walter L; von Bergwelt-Baildon MS; Koch J
Front Immunol; 2017; 8():387. PubMed ID: 28443091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
